rs9515203
Variant names: 
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001846.4(COL4A2):c.181-27458T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.258 in 152,192 control chromosomes in the GnomAD database, including 5,336 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
 Genomes: 𝑓 0.26   (  5336   hom.,  cov: 33) 
Consequence
 COL4A2
NM_001846.4 intron
NM_001846.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -1.42  
Publications
58 publications found 
Genes affected
 COL4A2  (HGNC:2203):  (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008] 
COL4A2 Gene-Disease associations (from GenCC):
- porencephaly 2Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- COL4A1 or COL4A2-related cerebral small vessel diseaseInheritance: AD Classification: MODERATE Submitted by: Illumina
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). 
BP6
Variant 13-110397276-T-C is Benign according to our data. Variant chr13-110397276-T-C is described in ClinVar as Benign. ClinVar VariationId is 1164920.Status of the report is criteria_provided_single_submitter, 1 stars. 
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.29  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| COL4A2 | NM_001846.4 | c.181-27458T>C | intron_variant | Intron 4 of 47 | ENST00000360467.7 | NP_001837.2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.258  AC: 39286AN: 152074Hom.:  5337  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
39286
AN: 
152074
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.258  AC: 39295AN: 152192Hom.:  5336  Cov.: 33 AF XY:  0.256  AC XY: 19036AN XY: 74394 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
39295
AN: 
152192
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
19036
AN XY: 
74394
show subpopulations 
African (AFR) 
 AF: 
AC: 
11223
AN: 
41520
American (AMR) 
 AF: 
AC: 
4540
AN: 
15288
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
756
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
623
AN: 
5188
South Asian (SAS) 
 AF: 
AC: 
774
AN: 
4828
European-Finnish (FIN) 
 AF: 
AC: 
2707
AN: 
10578
Middle Eastern (MID) 
 AF: 
AC: 
39
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
17729
AN: 
68000
Other (OTH) 
 AF: 
AC: 
492
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1499 
 2998 
 4497 
 5996 
 7495 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 378 
 756 
 1134 
 1512 
 1890 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
506
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.